Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136910367> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3136910367 endingPage "103" @default.
- W3136910367 startingPage "100" @default.
- W3136910367 abstract "Background: Sickle cell anemia (SCA) is an autosomal recessive disorder associated with high morbidity and mortality in children. Hydroxyurea (HU) has shown to decrease the frequency of vaso-occlusive crisis, hospitalization, and blood transfusion in SCA patients. Objective: The objective of the study was to evaluate the efficacy of HU on clinical and hematological parameters in pediatric patients with SCA. Materials and Methods: A prospective analytic study was conducted among 49 children aged between 5 and 14 years, diagnosed with SCA visiting the outpatient department at a tertiary care center of Central India for over a period of 13 months. Children enrolled in the study were given HU and they were followed at every 2-month for 6 months. Clinical and laboratory parameters of the study population were recorded and analyzed. With nine children lost to follow up, the final analysis was carried in only 40 patients. Results: Most of the children (60%) belonged to the age group of 5–9 years and male predominance (70%) was observed in the study. Clinical parameters including number of hospitalization, vaso-occlusive crisis, and frequency of blood transfusion decreased significantly (p<0.01). After 6 months of HU therapy, there was increase in hemoglobin levels (p=0.002), decrease in total leukocyte count (p=0.001), and platelet count was observed (p=0.283). Improvement in the serum glutamic pyruvic transaminase and serum creatinine (p<0.01), serum bilirubin, blood urea, and serum glutamic-oxaloacetic transaminase (p>0.05) was observed. No adverse reactions were noticed during this study period. Conclusion: HU is an effective drug and can be safely used for the treatment in SCA." @default.
- W3136910367 created "2021-03-29" @default.
- W3136910367 creator A5046596285 @default.
- W3136910367 creator A5079441269 @default.
- W3136910367 creator A5091901512 @default.
- W3136910367 date "2021-03-17" @default.
- W3136910367 modified "2023-09-26" @default.
- W3136910367 title "Impact of hydroxyurea therapy on clinicohematological parameters in children with sickle cell anemia" @default.
- W3136910367 doi "https://doi.org/10.32677/ijch.2021.v08.i02.008" @default.
- W3136910367 hasPublicationYear "2021" @default.
- W3136910367 type Work @default.
- W3136910367 sameAs 3136910367 @default.
- W3136910367 citedByCount "1" @default.
- W3136910367 countsByYear W31369103672022 @default.
- W3136910367 crossrefType "journal-article" @default.
- W3136910367 hasAuthorship W3136910367A5046596285 @default.
- W3136910367 hasAuthorship W3136910367A5079441269 @default.
- W3136910367 hasAuthorship W3136910367A5091901512 @default.
- W3136910367 hasBestOaLocation W31369103671 @default.
- W3136910367 hasConcept C126322002 @default.
- W3136910367 hasConcept C181199279 @default.
- W3136910367 hasConcept C185592680 @default.
- W3136910367 hasConcept C187212893 @default.
- W3136910367 hasConcept C197934379 @default.
- W3136910367 hasConcept C2776877979 @default.
- W3136910367 hasConcept C2777513400 @default.
- W3136910367 hasConcept C2778176769 @default.
- W3136910367 hasConcept C2778248108 @default.
- W3136910367 hasConcept C2778620579 @default.
- W3136910367 hasConcept C2778917026 @default.
- W3136910367 hasConcept C2779134260 @default.
- W3136910367 hasConcept C2780306776 @default.
- W3136910367 hasConcept C2908647359 @default.
- W3136910367 hasConcept C3020110884 @default.
- W3136910367 hasConcept C55493867 @default.
- W3136910367 hasConcept C71924100 @default.
- W3136910367 hasConcept C90924648 @default.
- W3136910367 hasConcept C99454951 @default.
- W3136910367 hasConceptScore W3136910367C126322002 @default.
- W3136910367 hasConceptScore W3136910367C181199279 @default.
- W3136910367 hasConceptScore W3136910367C185592680 @default.
- W3136910367 hasConceptScore W3136910367C187212893 @default.
- W3136910367 hasConceptScore W3136910367C197934379 @default.
- W3136910367 hasConceptScore W3136910367C2776877979 @default.
- W3136910367 hasConceptScore W3136910367C2777513400 @default.
- W3136910367 hasConceptScore W3136910367C2778176769 @default.
- W3136910367 hasConceptScore W3136910367C2778248108 @default.
- W3136910367 hasConceptScore W3136910367C2778620579 @default.
- W3136910367 hasConceptScore W3136910367C2778917026 @default.
- W3136910367 hasConceptScore W3136910367C2779134260 @default.
- W3136910367 hasConceptScore W3136910367C2780306776 @default.
- W3136910367 hasConceptScore W3136910367C2908647359 @default.
- W3136910367 hasConceptScore W3136910367C3020110884 @default.
- W3136910367 hasConceptScore W3136910367C55493867 @default.
- W3136910367 hasConceptScore W3136910367C71924100 @default.
- W3136910367 hasConceptScore W3136910367C90924648 @default.
- W3136910367 hasConceptScore W3136910367C99454951 @default.
- W3136910367 hasIssue "2" @default.
- W3136910367 hasLocation W31369103671 @default.
- W3136910367 hasOpenAccess W3136910367 @default.
- W3136910367 hasPrimaryLocation W31369103671 @default.
- W3136910367 hasRelatedWork W1584013717 @default.
- W3136910367 hasRelatedWork W2052436525 @default.
- W3136910367 hasRelatedWork W2076410551 @default.
- W3136910367 hasRelatedWork W2188642558 @default.
- W3136910367 hasRelatedWork W2373403743 @default.
- W3136910367 hasRelatedWork W2411339305 @default.
- W3136910367 hasRelatedWork W2533337701 @default.
- W3136910367 hasRelatedWork W2556127582 @default.
- W3136910367 hasRelatedWork W3032307753 @default.
- W3136910367 hasRelatedWork W2188421684 @default.
- W3136910367 hasVolume "8" @default.
- W3136910367 isParatext "false" @default.
- W3136910367 isRetracted "false" @default.
- W3136910367 magId "3136910367" @default.
- W3136910367 workType "article" @default.